Branca M. A. Silva

Branca M. A. Silva

Auto-generated profile, based on publicly available information

Branca M. A. Silva

Bluepharma-Indústria Farmacêutica, S.A., São Martinho do Bispo, 3045-016 Coimbra, Portugal; Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2013 in Medical Mycology
Verified
Journal Article
Open access
PDF file
BSBranca M.A. Silva
Branca M.A. Silva
RPRafael Prados-Rosales
Rafael Prados-Rosales
JEJavier Espadas-Moreno
Javier Espadas-Moreno
JWJulie M. Wolf
Julie M. Wolf
J. L. Luque-GarciaJ. L. Luque-Garcia
J. L. Luque-Garcia
ACArturo Casadevall
Arturo Casadevall
Many fungi use membrane vesicles to transport complex molecules across their cell walls. Like mammalian exosomes, fungal vesicles contain lipids, proteins, and polysaccharides, many of which are associated with virulence. Here we identify and characterize extracellular vesicles (EVs) in Alternaria infectoria, a ubiquitous, environmental filamentous fungus that is also an opportunistic human pathogen. Examination of the A. infectoria EVs revealed a morphology similar to that of vesicles described in other fungal species. Of note, proteomic analysis detected a reduced number of vesicle-associated proteins. There were two prevalent categories among the 20 identified proteins, including the polysaccharide metabolism group, probably related to plant host invasion or biosynthesis/degradation of cell wall components, and the nuclear proteins, especially DNA repair enzymes. We also found enzymes related to pigment synthesis, adhesion to the host cell, and trafficking of vesicles/organelles/molecules. This is the first time EV secretions have been identified in a filamentous fungus. We believe that these vesicles might have a role in virulence.

1 October 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
BSBranca M.A. Silva
Branca M.A. Silva
ABAna Filipa Borges
Ana Filipa Borges
CSCláudia Silva
Cláudia Silva
JCJorge Coelho
Jorge Coelho
SSSérgio Simões
Sérgio Simões

1 March 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
CFChantal Fernandes
Chantal Fernandes
RPRafael Prados-Rosales
Rafael Prados-Rosales
BSBranca M. A. Silva
Branca M. A. Silva
ANAntonio Nakouzi-Naranjo
Antonio Nakouzi-Naranjo
Mónica R. ZuzarteMónica R. Zuzarte
Mónica R. Zuzarte
Teresa GonçalvesTeresa Gonçalves
Teresa Gonçalves
The importance of Alternaria sp. fungi to human health ranges from being etiological agents of serious infections with poor prognosis in immunosuppressed individuals to their association with respiratory allergic diseases. The present work focuses on Alternaria infectoria, as a model organism of the genus, and was designed to unravel melanin production in the response to antifungals. After the characterization of the pigment produced by A. infectoria, we studied the dynamics of dihydroxynaphthalene (DHN)-melanin production during growth, the degree of melanization in response to antifungals, and how melanization affected the susceptibility to several classes of therapeutic drugs. We demonstrate that A. infectoria increased melanin deposition in the cell walls in response to nikkomycin Z, caspofungin and itraconazole but not in response to fluconazole or amphotericin B. These results indicated that A. infectoria activates DHN-melanin synthesis in response to certain fungal drugs, possibly as a protective mechanism against antifungal drugs. Inhibition of DHN-melanin synthesis by pyroquilon resulted in a lower minimum effective concentration (MEC) of caspofungin, with enhanced morphological changes (increased balloon size) characterized by thinner and less organized A. infectoria cell walls. In summary, A. infectoria synthesizes melanin in response to certain antifungal drugs and its susceptibility is influenced by melanization suggesting a therapeutic potential to drug combinations that affect melanin synthesis.

1 May 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
CFChantal Fernandes
Chantal Fernandes
JAJorge Anjos
Jorge Anjos
LWLouise A. Walker
Louise A. Walker
BSBranca M. A. Silva
Branca M. A. Silva
LCLuisa Cortes
Luisa Cortes
Teresa GonçalvesTeresa Gonçalves
Teresa Gonçalves
The present work reports the effects of caspofungin, a β-1,3-glucan synthase inhibitor, and nikkomycin Z, an inhibitor of chitin synthases, on two strains of Alternaria infectoria , a melanized fungus involved in opportunistic human infections and respiratory allergies. One of the strains tested, IMF006, bore phenotypic traits that conferred advantages in resisting antifungal treatment. First, the resting cell wall chitin content was higher and in response to caspofungin, the chitin level remained constant. In the other strain, IMF001, the chitin content increased upon caspofungin treatment to values similar to basal IMF006 levels. Moreover, upon caspofungin treatment, the FKS1 gene was upregulated in IMF006 and downregulated in IMF001. In addition, the resting β-glucan content was also different in both strains, with higher levels in IMF001 than in IMF006. However, this did not provide any advantage with respect to echinocandin resistance. We identified eight different chitin synthase genes and studied relative gene expression when the fungus was exposed to the antifungals under study. In both strains, exposure to caspofungin and nikkomycin Z led to modulation of the expression of class V and VII chitin synthase genes, suggesting its importance in the robustness of A. infectoria . The pattern of A. infectoria phagocytosis and activation of murine macrophages by spores was not affected by caspofungin. Monotherapy with nikkomycin Z and caspofungin provided only fungistatic inhibition, while a combination of both led to fungal cell lysis, revealing a strong synergistic action between the chitin synthase inhibitor and the β-glucan synthase inhibitor against this fungus.

1 August 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
BSBranca M.A. Silva
Branca M.A. Silva
SVSílvia Vicente
Sílvia Vicente
SCSofia Cunha
Sofia Cunha
JCJorge Coelho
Jorge Coelho
CSCláudia Silva
Cláudia Silva
SSSérgio Simões
Sérgio Simões

1 October 2012 in Medical Mycology
Verified
Journal Article
Open access
PDF file
JAJorge Anjos
Jorge Anjos
CFChantal Fernandes
Chantal Fernandes
BSBranca M. A. Silva
Branca M. A. Silva
CQCelia Quintas
Celia Quintas
AAAlexandra Abrunheiro
Alexandra Abrunheiro
Teresa GonçalvesTeresa Gonçalves
Teresa Gonçalves
The fungal cell wall polymer β-(1,3)-D-glucan is synthesized by the enzyme β-(1,3)-D-glucan synthase that is a complex composed of at least two prote